Arkolith/Insider Trading/CGON/Form 4

Mulay James

DirectorCG Oncology, Inc. (CGON) · full profile →Form 4 · filed Jan 13, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$585K
Net Open-Market Flow
-$585K
Transactions
6
4 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 9, 2026Sell(S)10K$52.99$556K0
Jan 9, 2026Sell(S)654$44.16$29K0
Jan 9, 2026Option exercise(M)654$3.72$2K654
Jan 9, 2026Option exercise(M)10K$12.59$132K10K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 9, 2026Option exercise(M)10K—$05K
Jan 9, 2026Option exercise(M)654—$01K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-011756) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML